- Home
- PRPO vs UPXI Comparison
PRPO vs UPXI Comparison
Compare PRPO & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- UPXI
- Stock Information
- Founded
- PRPO N/A
- UPXI 2018
- Country
- PRPO United States
- UPXI United States
- Employees
- PRPO 57
- UPXI N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- PRPO Industrials
- UPXI Health Care
- Exchange
- PRPO Nasdaq
- UPXI Nasdaq
- Market Cap
- PRPO 9.5M
- UPXI 3.4M
- IPO Year
- PRPO N/A
- UPXI 2021
- Fundamental
- Price
- PRPO $6.59
- UPXI $3.66
- Analyst Decision
- PRPO
- UPXI Hold
- Analyst Count
- PRPO 0
- UPXI 1
- Target Price
- PRPO N/A
- UPXI $1.25
- AVG Volume (30 Days)
- PRPO 7.9K
- UPXI 301.2K
- Earning Date
- PRPO 11-11-2024
- UPXI 11-12-2024
- Dividend Yield
- PRPO N/A
- UPXI N/A
- EPS Growth
- PRPO N/A
- UPXI N/A
- EPS
- PRPO N/A
- UPXI N/A
- Revenue
- PRPO $16,719,999.00
- UPXI $83,980,115.00
- Revenue This Year
- PRPO $75.18
- UPXI $18.98
- Revenue Next Year
- PRPO N/A
- UPXI $8.09
- P/E Ratio
- PRPO N/A
- UPXI N/A
- Revenue Growth
- PRPO 52.61
- UPXI 27.11
- 52 Week Low
- PRPO $4.31
- UPXI $2.17
- 52 Week High
- PRPO $8.99
- UPXI $33.00
- Technical
- Relative Strength Index (RSI)
- PRPO 52.82
- UPXI 57.50
- Support Level
- PRPO $6.42
- UPXI $2.40
- Resistance Level
- PRPO $6.99
- UPXI $4.32
- Average True Range (ATR)
- PRPO 0.33
- UPXI 0.69
- MACD
- PRPO -0.04
- UPXI 0.14
- Stochastic Oscillator
- PRPO 69.91
- UPXI 70.78
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About UPXI Upexi Inc.
Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.